S. Margolin

587 total citations
28 papers, 457 citations indexed

About

S. Margolin is a scholar working on Physiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Margolin has authored 28 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Margolin's work include Pain Mechanisms and Treatments (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Gastrointestinal motility and disorders (3 papers). S. Margolin is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Gastrointestinal motility and disorders (3 papers). S. Margolin collaborates with scholars based in United States, South Korea and United Kingdom. S. Margolin's co-authors include M. Kletzkin, B. J. Ludwig, Shri N. Giri, Lei Feng, F. M. Berger, Stanley S. Lefkowitz, Doris L. Lefkowitz, Kohji Shirai, J. F. Douglas and Masami Nemoto and has published in prestigious journals such as Nature, Science and Annals of the New York Academy of Sciences.

In The Last Decade

S. Margolin

27 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Margolin United States 10 123 92 81 53 53 28 457
Jessie Marmorston United States 19 150 1.2× 79 0.9× 97 1.2× 77 1.5× 48 0.9× 65 842
John H. Ball United States 8 62 0.5× 161 1.8× 97 1.2× 58 1.1× 95 1.8× 11 480
S. Fujimoto Japan 11 73 0.6× 80 0.9× 78 1.0× 59 1.1× 24 0.5× 28 331
W. Schopman Netherlands 12 79 0.6× 94 1.0× 39 0.5× 67 1.3× 88 1.7× 47 429
Neil I. Kaminsky United States 9 144 1.2× 271 2.9× 141 1.7× 117 2.2× 133 2.5× 13 866
R Gross Germany 15 76 0.6× 138 1.5× 128 1.6× 57 1.1× 57 1.1× 57 621
Jacob Grossman United States 13 143 1.2× 99 1.1× 66 0.8× 36 0.7× 81 1.5× 22 440
H. N. Haugen Norway 11 90 0.7× 81 0.9× 52 0.6× 49 0.9× 88 1.7× 34 452
Mary Ellen Parks United States 12 85 0.7× 152 1.7× 79 1.0× 25 0.5× 121 2.3× 20 492
G. Peters Switzerland 12 89 0.7× 110 1.2× 52 0.6× 29 0.5× 77 1.5× 39 447

Countries citing papers authored by S. Margolin

Since Specialization
Citations

This map shows the geographic impact of S. Margolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Margolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Margolin more than expected).

Fields of papers citing papers by S. Margolin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Margolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Margolin. The network helps show where S. Margolin may publish in the future.

Co-authorship network of co-authors of S. Margolin

This figure shows the co-authorship network connecting the top 25 collaborators of S. Margolin. A scholar is included among the top collaborators of S. Margolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Margolin. S. Margolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Lei, et al.. (2008). Effects of three anti-TNF-α drugs: Etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro. International Immunopharmacology. 8(5). 679–687. 86 indexed citations
2.
Bao, Lihua, Yong‐Jin Kim, In Ho Cho, et al.. (2003). Pirfenidone Suppressed the Development of Glomerulosclerosis in the FGS/Kist mouse. Journal of Korean Medical Science. 18(4). 527–527. 16 indexed citations
3.
Waller, J R, Deirdre Toomey, M.S. Metcalfe, S. Margolin, & Michael L. Nicholson. (2002). Pirfenidone inhibits early neointimal proliferation following arterial injury. Transplantation Proceedings. 34(5). 1486–1488. 1 indexed citations
4.
Shetlar, M. R., et al.. (1998). Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone. Journal of Laboratory and Clinical Medicine. 132(6). 491–496. 23 indexed citations
5.
Lefkowitz, Doris L., et al.. (1998). Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone. International Journal of Immunopharmacology. 20(12). 685–695. 74 indexed citations
6.
Berger, F. M., J. F. Douglas, B. J. Ludwig, & S. Margolin. (1969). The effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) on experimental atherosclerosis and hypercholesteremia.. PubMed. 170(2). 371–81. 6 indexed citations
7.
Berger, F. M., J. F. Douglas, B. J. Ludwig, & S. Margolin. (1969). THE EFFECT OF N-γ-PHENYLPROPYL-N-BENZYLOXY ACETA- MIDE (W-1372) ON EXPERIMENTAL ATHEROSCLEROSIS AND HYPERCHOLESTEREMIA. Journal of Pharmacology and Experimental Therapeutics. 170(2). 371–381. 1 indexed citations
8.
Margolin, S., et al.. (1968). Further Evidence for an Unique Neurohumoral Agent Released from Brain by Morphine Given Intracerebrally. Experimental Biology and Medicine. 128(1). 317–321. 3 indexed citations
9.
Margolin, S., et al.. (1968). Endotoxin-Induced Inhibition of Renal Function in the Mouse. Experimental Biology and Medicine. 129(2). 642–646. 9 indexed citations
10.
Berger, F. M., et al.. (1967). Selective Suppression of Penicillin Hypersensitivity by Certain Phenoxy Propanediols. Experimental Biology and Medicine. 124(1). 303–310. 5 indexed citations
11.
Kletzkin, M., et al.. (1966). Tranquillizers in Pregnancy and Behavioural Effects on the Offspring. Nature. 210(5042). 1290–1291. 2 indexed citations
12.
Margolin, S., et al.. (1965). A Neurohumoral Substance Discharged into Blood Perfusate from Isolated Rabbit Heads by Intracerebral Morphine. Pharmacology. 12(1). 1–7. 5 indexed citations
13.
Kletzkin, M., et al.. (1964). Postnatal Behavioural Effects of Meprobamate injected into the Gravid Rat. Nature. 204(4964). 1206–1206. 7 indexed citations
14.
Margolin, S., et al.. (1963). SELECTIVE INHIBITION OF DOG SPINAL VASOCONSTRICTOR TRACTS BY MEBUTAMATE. Journal of Pharmacology and Experimental Therapeutics. 140(2). 170–178. 5 indexed citations
15.
Berger, F. M., J. F. Douglas, B. J. Ludwig, & S. Margolin. (1963). Effect of Benzyl N-Benzyl Carbethoxyhydroxamate (W-398) on Experimental Atherosclerosis and Hypercholesteremia. Experimental Biology and Medicine. 114(2). 337–341. 5 indexed citations
16.
Margolin, S.. (1963). Centrally Mediated Inhibition of Gastrointestinal Propulsive Motility By Morphine over a Non-Neural Pathway. Experimental Biology and Medicine. 112(2). 311–315. 16 indexed citations
17.
Berger, F. M., J. F. Douglas, M. Kletzkin, B. J. Ludwig, & S. Margolin. (1961). THE PHARMACOLOGICAL PROPERTIES OF 2-METHYL-2-SEC-BUTYL-1,3-PROPANEDIOL DICARBAMATE (MEBUTAMATE, W-583), A NEW CENTRALLY ACTING BLOOD PRESSURE LOWERING AGENT. Journal of Pharmacology and Experimental Therapeutics. 134(3). 356–365. 13 indexed citations
18.
Kletzkin, M., et al.. (1960). THE HISTORY, CHEMISTRY, AND PHARMACOLOGY OF CARISOPRODOL. Annals of the New York Academy of Sciences. 86(1). 90–107. 31 indexed citations
19.
Margolin, S.. (1960). Pharmacologic Demonstration in Man of Increased Thresholds to Tooth Pain Following Carisoprodol and other Analgesics. Experimental Biology and Medicine. 105(3). 531–533. 9 indexed citations
20.
Berger, F. M., et al.. (1959). UNUSUAL MUSCLE RELAXANT AND ANALGESIC PROPERTIES OF N-ISOPROPYL-2-METHYL-2-PROPYL-1, 3-PROPANEDIOL DICARBAMATE (CARISOPRODOL). Journal of Pharmacology and Experimental Therapeutics. 127(1). 66–74. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessie Marmorston Breakdown of academic impact, for papers by John H. Ball Breakdown of academic impact, for papers by S. Fujimoto Breakdown of academic impact, for papers by W. Schopman Breakdown of academic impact, for papers by Neil I. Kaminsky Breakdown of academic impact, for papers by R Gross Breakdown of academic impact, for papers by Jacob Grossman Breakdown of academic impact, for papers by H. N. Haugen Breakdown of academic impact, for papers by Mary Ellen Parks Breakdown of academic impact, for papers by G. Peters
Rankless by CCL
2026